Literature DB >> 20736845

Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA).

Athanasios Christoforidis1, Marina Economou, Eleni Papadopoulou, Eirini Kazantzidou, Nikolaos Gompakis, Miranda Athanassiou-Metaxa.   

Abstract

Recent studies report reduced bone mineral density (BMD) even among young adults and children with hemophilia. Our aim was to assess bone status in children and adolescents with hemophilia with 2 methods: Quantitative UltraSonography (QUS) and Dual energy x-ray Absorptiometry (DXA), and consequently to investigate the degree of correlation between them. Twenty-seven patients (17 with severe hemophilia; residual factor activity <1% and 10 with moderate hemophilia) participated in the study. Mean age was 12.28±4.48 y (range: 4.94 to 18.00 y). All patients were evaluated with QUS at radius and at tibia and had DXA scan at lumbar spine. Anthropometric parameters were measured using standard techniques and joint evaluation was carried out using the Hemophilia Joint Health Score (HJHS). Only 2 out of 27 patients (7.5%) had BMD Z-scores <-2, whereas another 4 patients (15%) had BMD Z-scores between -1 and -2. QUS values in both radius and tibia were generally within the normal limits as only 1 patient had radius and another 1 had tibia QUS Z-score <-2. HJH scores were significantly although negatively correlated to Z-scores of tibia QUS (r=-0.455, P=0.034). No correlations were observed between lumbar BMD and radius or tibia QUS and no agreement was recorded between QUS and DXA in identifying patients at risk for osteoporosis (k=0.262). In conclusion, our study showed that only a small number of children and young adults with hemophilia have impaired bone properties as assessed both by DXA and QUS; no correlation was observed between these 2 methods.

Entities:  

Mesh:

Year:  2010        PMID: 20736845     DOI: 10.1097/MPH.0b013e3181e8cd40

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

1.  Bone mineral density in hemophilia patients.

Authors:  Nader Roushan; Alipasha Meysamie; Mohammadreza Managhchi; Javad Esmaili; Tarane Dormohammadi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

2.  Prevalence of Bone Density Reduction and Its Related Factors in Hemophilia Patients in South Khorasan Province in 2018.

Authors:  Alireza Ehsanbakhsh; Ghodsiyeh Azarkar; Masood Ziaee; Ali Taghavieh
Journal:  Galen Med J       Date:  2020-08-27

3.  Bone status measured by quantitative ultrasound: a comparison with DXA in Thai children.

Authors:  W Srichan; W Thasanasuwan; K Kijboonchoo; N Rojroongwasinkul; W Wimonpeerapattana; I Khouw; P Deurenberg
Journal:  Eur J Clin Nutr       Date:  2015-10-28       Impact factor: 4.016

Review 4.  Low Bone Mineral Density in Hemophiliacs.

Authors:  Jennifer Gebetsberger; Michael Schirmer; Walter J Wurzer; Werner Streif
Journal:  Front Med (Lausanne)       Date:  2022-02-02

Review 5.  Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines.

Authors:  Madison J Petkovic; Huyen A Tran; Peter R Ebeling; Ayse Zengin
Journal:  Haemophilia       Date:  2022-03-15       Impact factor: 4.263

6.  Comparison of quantitative ultrasonography and dual X-ray absorptiometry for bone status assessment in South African children living with HIV.

Authors:  Jackson A Roberts; Yanhan Shen; Renate Strehlau; Faeezah Patel; Louise Kuhn; Ashraf Coovadia; Jonathan J Kaufman; Stephanie Shiau; Stephen M Arpadi; Michael T Yin
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

7.  Evaluation of bone mineralization in former preterm born children: Phalangeal quantitative ultrasound cannot replace dual-energy X-ray absorptiometry.

Authors:  Carmen M T Lageweg; Mayke E van der Putten; Johannes B van Goudoever; Ton Feuth; Martin Gotthardt; Arno F J van Heijst; Viola Christmann
Journal:  Bone Rep       Date:  2018-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.